Many youth with blood cancers receive intensive end-of-life care

Many youth with blood cancers receive intensive end-of-life care

(HealthDay)—Fifty-five percent of children, adolescents, and young adults with hematologic malignancies experience high-intensity end-of-life care (HI-EOLC), with an increased likelihood for those treated at medium or large hospitals, according to a study published online June 29 in Cancer.

Sophia Mun, M.P.H., from the Yale Cancer Outcomes, Public Policy, and Effectiveness Research Center in New Haven, Connecticut, and colleagues conducted a population-based retrospective cohort study involving individuals with aged 0 to 39 years at death, who died between 2010 and 2017. Patient sociodemographic and hospital characteristics associated with HI-EOLC were examined.

The researchers found that 55 percent of the 1,454 decedents experienced HI-EOLC. The likelihood of receiving HI-EOLC was increased for patients treated in medium or large hospitals (adjusted odds ratios, 1.63 and 2.21, respectively), insured by Medicaid (adjusted odds ratio, 1.40), or receiving cancer-directed treatment in the Northeast (adjusted odds ratio, 1.50).

"Insurance type, hospital size, and hospital region appear to significantly influence the receipt of HI-EOLC," the authors write. "Mitigation strategies may include earlier integration of palliative and/or when feasible as well as a policy change that enables interventions such as transfusions to occur in settings outside the hospital."

One author disclosed financial ties to the biopharmaceutical industry.


Explore further

ED visits for leiomyomas increased from 2006 to 2017

More information: Abstract/Full Text (subscription or payment may be required)
Journal information: Cancer

Copyright © 2021 HealthDay. All rights reserved.

Citation: Many youth with blood cancers receive intensive end-of-life care (2021, July 6) retrieved 17 September 2021 from https://medicalxpress.com/news/2021-07-youth-blood-cancers-intensive-end-of-life.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
1 shares

Feedback to editors